Loratadine

Manufacturer
Premier Value | Ohm Laboratories | Ohm Laboratories Inc.
Effective date
2024-12-27
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:49:20

Label at a glance#

ProductLoratadine
Active ingredientLORATADINE
Label structure11 sections

Indications and uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

Dosage and administration

adults and children 6 years and over chew 2 tablets daily; not more than 2 tablets in 24 hours children 2 to under 6 years of age chew 1 tablet daily; not more than 1 tablet in 24 hours children under 2 years of age ask a doctor consumers with liver or kidney disease ask a doctor

Storage and handling

phenylketonurics: contains phenylalanine 1.25 mg per tablet. TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING. store between 20° to 25°C (68° to 77°F).

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Loratadine USP, 5 mg

Purpose

OTC - PURPOSE SECTION

Antihistamine

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • itchy, watery eyes
  • sneezing
  • itching of the nose or throat

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not useif you have ever had an allergic reaction to this product or any of its ingredients.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you haveliver or kidney disease. Your doctor should determine if you need a different dose.

OTC - WHEN USING SECTION

When using this productdo not take more than directed. Taking more than directed may cause drowsiness.

OTC - STOP USE SECTION

Stop use and ask a doctor ifan allergic reaction to this product occurs. Seek medical help right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding,ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 6 years and overchew 2 tablets daily; not more than 2 tablets in 24 hours
children 2 to under 6 years of agechew 1 tablet daily; not more than 1 tablet in 24 hours
children under 2 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor

Other information

STORAGE AND HANDLING SECTION

  • phenylketonurics: contains phenylalanine 1.25 mg per tablet.
  • TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
  • store between 20° to 25°C (68° to 77°F).

Inactive ingredients

INACTIVE INGREDIENT SECTION

aspartame, citric acid anhydrous, colloidal silicon dioxide, D&C red No. 27 aluminum lake, FD&C blue No. 2 aluminum lake, flavor, magnesium stearate, mannitol, microcrystalline cellulose, sodium starch glycolate, stearic acid

Questions?

OTC - QUESTIONS SECTION

call 1-800-406-7984

SPL UNCLASSIFIED SECTION

Distributed By:
Pharmacy Value Alliance, LLC
407 East Lancaster Avenue,
Wayne, PA 19087

PRINCIPAL DISPLAY PANEL - 5 mg Blister Pack Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

†COMPARE TO THE ACTIVE
INGREDIENT OF CHILDREN'S
CLARITIN ®CHEWABLES
NON-DROWSY*

Premier
Value ®

Children's Loratadine Chewable
Tablets USP, 5 mg
Antihistamine

Indoor & Outdoor Allergies

Grape

ages 2 years
and older

24 Hour Relief of:

  • Sneezing; Runny Nose; Itchy, Watery Eyes,
    Itchy Throat or Nose

30 Chewable Tablets
The chewable tablets are to be chewed before swallowing.
*When taken as directed. See Drug Facts Panel.

INDEPENDENTLY TESTED
SATISFACTION GUARANTEED

PRINCIPAL DISPLAY PANEL - 5 mg Blister Pack Carton
PRINCIPAL DISPLAY PANEL - 5 mg Blister Pack Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
665078loratadine 5 MG 24HR Chewable TabletPSN2
665078loratadine 5 MG Chewable TabletSCD2

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
68016-053-10Loratadine1 in 1 CARTONTABLET12
68016-053-10Loratadine10 in 1 BLISTER PACKTABLET102
68016-053-30Loratadine30 in 1 BLISTER PACKTABLET302
68016-053-30Loratadine1 in 1 CARTONTABLET12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
68016-053LORATADINE TABLET [PREMIER VALUE]2Current NDC, Legacy NDC, 4 package rows20241228_dc22862e-fe91-4900-8c2b-1ca45aeedbf0.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
68016-05368016-053-10, 68016-053-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML · Source PDF

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210088-001LORATADINELORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16
A210088-002LORATADINELORATADINE10MGTABLET, CHEWABLE / ORAL2025-04-25

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 49 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-1684e616aacf4f…
2026-09-14 22:38:342026-08A210088-002LORATADINE10MGTABLET, CHEWABLE / ORAL2025-04-2584e616aacf4f…
2026-08-18 06:07:402026-07A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16caaa826d4ba7…
2026-08-18 06:07:402026-07A210088-002LORATADINE10MGTABLET, CHEWABLE / ORAL2025-04-25caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16011fe1cb6892…
2026-02-19 14:30 UTC2026-02A210088-002LORATADINE10MGTABLET, CHEWABLE / ORAL2025-04-25011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-1631067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210088-002LORATADINE10MGTABLET, CHEWABLE / ORAL2025-04-2531067a03dcf5…
2025-08-23 18:47 UTC2025-08A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-166a471c1ec25d…
2025-08-23 18:47 UTC2025-08A210088-002LORATADINE10MGTABLET, CHEWABLE / ORAL2025-04-256a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-1603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-162680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-165bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-1679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-161e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-168072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-165c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-165d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-164b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-1674a2ff9319b5…
2022-03-09 01:35 UTC2022-03A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-1687673890dc5c…
2021-03-12 10:30 UTC2021-03A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-165aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-168869cabd3fbd…
2020-11-12 02:37 UTC2020-11A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16c0c555d07b60…
2019-12-14 00:12 UTC2019-12A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-163f01610625f2…
2019-09-15 20:21 UTC2019-09A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16b00525d2431f…
2019-07-19 19:46 UTC2019-07A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-166a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-161c564ffb4f44…
2023-12-20 04:57 UTC2023-12A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-169b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A210088-001LORATADINE5MGTABLET, CHEWABLE / ORAL2018-04-16a67488948f0b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LoratadineLORATADINEPremier Valuedc22862e-fe91-4900-8c2b-1ca45aeedbf02024-12-27WarningsExact identifier
ndc (package): 68016-053-10
ndc (package): 68016-053-30
ndc (product): 68016-053
ndc11 (package): 68016005310
ndc11 (package): 68016005330
spl id: 2a409885-2a3e-34d8-e063-6394a90aa4d9
spl set id: dc22862e-fe91-4900-8c2b-1ca45aeedbf0

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.